TMRC CO LTD has a total of 26 patent applications. Its first patent ever was published in 2005. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Japan. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are FAUSTUS FORSCHUNG TRANSLATIONA, BEIJING UNION PHARMACEUTICAL FACTORY and TELORMEDIX SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Japan | 3 | |
#4 | China | 2 | |
#5 | Republic of Korea | 2 | |
#6 | United States | 2 | |
#7 | Australia | 1 | |
#8 | Canada | 1 | |
#9 | Hong Kong | 1 | |
#10 | Mexico | 1 | |
#11 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Ekimoto Hisao | 17 |
#2 | Sugiyama Hiroshi | 2 |
#3 | Yokumoto Hisao | 2 |
#4 | Bando Toshikazu | 2 |
#5 | Kadota Shigetoshi | 1 |
#6 | Hisao Ekimoto | 1 |
#7 | Toshikazu Bando | 1 |
#8 | Ueno Takeshi | 1 |
#9 | Ekimoto Hsiao | 1 |
#10 | Hiroshi Sugiyama | 1 |
Publication | Filing date | Title |
---|---|---|
WO2015045037A1 | Capsule preparation | |
JP2013199458A | Capsule preparation | |
JP2011022002A | Method for evaluating candidate substance for anti-cancer agent | |
EP2177525A1 | Metal complex compound, cancer therapeutic composition comprising the metal complex compound as active ingredient, and intermediate for production of the metal complex compound | |
CN101641091A | Tamibarotene capsule preparation | |
EP2005954A2 | Kit for cancer therapy and pharmaceutical composition for cancer therapy | |
JP2007284377A | Columbiadin compound and antitumor agent | |
US2008069901A1 | Therapeutic Agent for Metastatic Cancer and Cancer Metastasis Inhibitor | |
EP1731519A1 | Novel indole derivative for alkylating specific base sequence of dna and alkylating agent and drug each comprising the same |